{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:52Z","timestamp":1786119232278,"version":"build-2736575974"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/cad.0b013e3283043574","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T13:28:45Z","timestamp":1236259725000},"page":"673-680","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of mucosa-associated lymphoid tissue-type ocular adnexal lymphoma"],"prefix":"10.1097","volume":"19","author":[{"given":"Didier","family":"Decaudin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Lumbroso-Le Rouic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210203","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(84)90051-8","article-title":"Lymphoreticular tumors of the orbit","volume":"10","author":"Fitzpatrick","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-2-20210203","first-page":"205","article-title":"Radiotherapy of intraocular and orbital tumors","author":"Lambo","year":"1993"},{"key":"R3-2-20210203","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archopht.1952.00920010336008","article-title":"Ocular involvement in lymphomatous disease","volume":"48","author":"Feinstein","year":"1952","journal-title":"Am Arch Ophthalmol"},{"key":"R4-2-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0161-6420(98)92107-8","article-title":"Malignant tumors of the orbit. Analysis of the Florida Cancer Registry","volume":"105","author":"Margo","year":"1998","journal-title":"Ophthalmology"},{"key":"R5-2-20210203","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting \u2013 Airlie House, Virginia, November","volume":"17","author":"Harris","year":"1997","journal-title":"J Clin Oncol"},{"key":"R6-2-20210203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hon.741","article-title":"Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors","volume":"22","author":"Meunier","year":"2004","journal-title":"Hematol Oncol"},{"key":"R7-2-20210203","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood-2006-02-005017","article-title":"Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options","volume":"108","author":"Decaudin","year":"2006","journal-title":"Blood"},{"key":"R8-2-20210203","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428199909058411","article-title":"Histology according to the Revised European\u2013American Lymphoma classification significantly predicts the prognosis of ocular adnexal lymphoma","volume":"32","author":"Nakata","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"R9-2-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.10332","article-title":"Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients","volume":"73","author":"Cho","year":"2003","journal-title":"Am J Hematol"},{"key":"R10-2-20210203","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"R11-2-20210203","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-1827.2004.01580.x","article-title":"No evidence of a correlation between BCL10 expression API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma","volume":"54","author":"Adachi","year":"2004","journal-title":"Pathol Intern"},{"key":"R12-2-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0167-8140(95)01658-9","article-title":"A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas","volume":"38","author":"Esik","year":"1996","journal-title":"Radiother Oncol"},{"key":"R13-2-20210203","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"R14-2-20210203","first-page":"1860","article-title":"Report of the Committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"R15-2-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-8140(88)90218-6","article-title":"Orbital and conjunctival lymphoma treatment and prognosis","volume":"13","author":"Bessell","year":"1988","journal-title":"Radiother Oncol"},{"key":"R16-2-20210203","first-page":"61","article-title":"Malignant non-Hodgkin's lymphoma of the conjunctiva. A propos of 14 cases treated at the Institut Gustave-Roussy","volume":"77","author":"Vitu","year":"1990","journal-title":"Bull Cancer Radiother"},{"key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0167-8140(91)90067-Q","article-title":"Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma","volume":"22","author":"Letschert","year":"1991","journal-title":"Radiother Oncol"},{"key":"R18-2-20210203","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0360-3016(93)90173-S","article-title":"Radiotherapy is successful treatment for orbital lymphoma","volume":"26","author":"Smitt","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-2-20210203","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0360-3016(94)00416-1","article-title":"Radiation therapy for primary orbital lymphoma","volume":"31","author":"Chao","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-2-20210203","first-page":"474","article-title":"Orbital lymphoma: results of radiation therapy","volume":"27","author":"Lau","year":"1998","journal-title":"Ann Acad Med Singapore"},{"key":"R21-2-20210203","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/030089169708300509","article-title":"Radiation therapy for stage I primary orbital non-Hodgkin's lymphomas","volume":"83","author":"Erkal","year":"1997","journal-title":"Tumori"},{"key":"R22-2-20210203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(98)00535-5","article-title":"Radiotherapy in the management of orbital lymphoma","volume":"44","author":"Bolek","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-2-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","article-title":"Orbital lymphoma: radiotherapy outcome and complications","volume":"59","author":"Stafford","year":"2001","journal-title":"Radiother Oncol"},{"key":"R24-2-20210203","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0360-3016(02)02966-8","article-title":"Curative radiotherapy for primary orbital lymphoma","volume":"54","author":"Bhatia","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-2-20210203","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0360-3016(01)02729-8","article-title":"Primary radiotherapy for localized orbital MALT lymphoma","volume":"52","author":"Le","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-2-20210203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1076\/orbi.21.2.117.7192","article-title":"Results of radiotherapy for orbital and adnexal lymphoma","volume":"21","author":"Liao","year":"2002","journal-title":"Orbit"},{"key":"R27-2-20210203","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0360-3016(03)00506-6","article-title":"Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification","volume":"57","author":"Hasegawa","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R28-2-20210203","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","article-title":"Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy","volume":"55","author":"Martinet","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R29-2-20210203","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal-zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"key":"R30-2-20210203","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00428-005-0122-0","article-title":"Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases","volume":"448","author":"Charlotte","year":"2006","journal-title":"Virchows Arch"},{"key":"R31-2-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2005.11.005","article-title":"Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy","volume":"78","author":"Ejima","year":"2005","journal-title":"Radiother Oncol"},{"key":"R32-2-20210203","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood-2005-06-2332","article-title":"Ocular adnexal lymphoma: a clinicopathological study of a large cohort of patients with no evidence for an association with Chlamydia psittaci","volume":"107","author":"Rosado","year":"2006","journal-title":"Blood"},{"key":"R33-2-20210203","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2005.11.035","article-title":"Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behaviour","volume":"65","author":"Suh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-2-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-004-0914-3","article-title":"Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa","volume":"84","author":"Lee","year":"2005","journal-title":"Ann Hematol"},{"key":"R35-2-20210203","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0161-6420(95)30764-6","article-title":"Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type","volume":"102","author":"White","year":"1995","journal-title":"Ophthalmology"},{"key":"R36-2-20210203","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-007-0301-y","article-title":"Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas","volume":"86","author":"Rigacci","year":"2007","journal-title":"Ann Hematol"},{"key":"R37-2-20210203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/028418601750288217","article-title":"Non-Hodgkin's lymphoma of the ocular adnexa","volume":"40","author":"Sasai","year":"2001","journal-title":"Acta Oncol"},{"key":"R38-2-20210203","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0161-6420(00)00591-1","article-title":"Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report","volume":"108","author":"Blasi","year":"2001","journal-title":"Ophthalmology"},{"key":"R39-2-20210203","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0167-5699(94)90276-3","article-title":"CD20: a regulator of cell-type progression of B lymphocytes","volume":"15","author":"Tedder","year":"1994","journal-title":"Immunol Today"},{"key":"R40-2-20210203","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B-cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"R41-2-20210203","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood.V91.5.1644","article-title":"Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies","volume":"91","author":"Shan","year":"1998","journal-title":"Blood"},{"key":"R42-2-20210203","first-page":"7170","article-title":"Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways","volume":"60","author":"Mathas","year":"2000","journal-title":"Cancer Res"},{"key":"R43-2-20210203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/cbr.1997.12.177","article-title":"Chimeric anti-CD20 (IDEC-c2b8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs","volume":"12","author":"Demidem","year":"1997","journal-title":"Cancer Biother Radiopharm"},{"key":"R44-2-20210203","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1046\/j.1365-2141.2001.03014.x","article-title":"Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity either drug alone","volume":"114","author":"Di Gaetano","year":"2001","journal-title":"Br J Haematol"},{"key":"R45-2-20210203","first-page":"951","article-title":"Clinical activity and safety of combination immunotherapy with IFN-alpha2a and rituximab in patients with relapsed low grade non-Hodgkin's lymphoma","volume":"86","author":"Sacchi","year":"2001","journal-title":"Haematologica"},{"key":"R46-2-20210203","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1200\/JCO.2004.04.020","article-title":"Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up","volume":"22","author":"Czuczman","year":"2004","journal-title":"J Clin Oncol"},{"key":"R47-2-20210203","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood.V104.11.160.160","article-title":"Rituximab added to \u03b1IFN+CHVP improves the outcome of follicular lymphoma patients with a high tumor burden: first analysis of the GELA-GOELAMS FL-2000 randomized trial in 359 patients","volume":"104","author":"Salles","year":"2004","journal-title":"Blood"},{"key":"R48-2-20210203","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","article-title":"Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"key":"R49-2-20210203","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","article-title":"CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma","volume":"105","author":"Marcus","year":"2005","journal-title":"Blood"},{"key":"R50-2-20210203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"R51-2-20210203","first-page":"3121","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"Blood"},{"key":"R52-2-20210203","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncology"},{"key":"R53-2-20210203","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT-type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"R54-2-20210203","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000074641","article-title":"Rituximab for treatment of advanced extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue lymphoma","volume":"65","author":"Raderer","year":"2003","journal-title":"Oncology"},{"key":"R55-2-20210203","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1080\/1042819032000159889","article-title":"Rituximab-induced remission of a gastric MALT lymphoma","volume":"45","author":"Datta","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R56-2-20210203","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0609.2004.00299.x","article-title":"Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva","volume":"73","author":"Nuckel","year":"2004","journal-title":"Eur J Haematol"},{"key":"R57-2-20210203","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0181-5512(05)80991-X","article-title":"New treatment for orbital non-Hodgkin's lymphoma: 2 cases treated with rituximab","volume":"28","author":"Benabid","year":"2005","journal-title":"J Fr Ophthalmol"},{"key":"R58-2-20210203","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1080\/10428190500137890","article-title":"Regression of pulmonary MALT lymphoma after treatment with rituximab","volume":"46","author":"Chong","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R59-2-20210203","first-page":"1578","article-title":"Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa","volume":"90","author":"Ferreri","year":"2005","journal-title":"Haematologica"},{"key":"R60-2-20210203","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","article-title":"Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy","volume":"23","author":"Martinelli","year":"2005","journal-title":"J Clin Oncol"},{"key":"R61-2-20210203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.leukres.2004.05.011","article-title":"Rituximab in primary conjunctiva lymphoma","volume":"29","author":"Zinzani","year":"2005","journal-title":"Leuk Res"},{"key":"R62-2-20210203","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00277-006-0134-0","article-title":"Rituximab as first line treatment for MALT lymphoma of extraocular muscles","volume":"85","author":"Benetatos","year":"2006","journal-title":"Ann Hematol"},{"key":"R63-2-20210203","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10620-006-3205-0","article-title":"Successful treatment of Helicobacter pylori-negative gastric MALT lymphoma with rituximab","volume":"51","author":"Chaudhary","year":"2006","journal-title":"Dig Dis Sci"},{"key":"R64-2-20210203","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1023\/A:1008327301372","article-title":"Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa","volume":"9","author":"Baldini","year":"1998","journal-title":"Ann Oncol"},{"key":"R65-2-20210203","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ophtha.2003.09.049","article-title":"Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma","volume":"111","author":"Matsuo","year":"2004","journal-title":"Ophthalmology"},{"key":"R66-2-20210203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/annonc\/mdj025","article-title":"Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma","volume":"17","author":"Tanimoto","year":"2006","journal-title":"Ann Oncol"},{"key":"R67-2-20210203","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphoma","volume":"96","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R68-2-20210203","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1200\/JCO.2005.07.083","article-title":"Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy","volume":"23","author":"Ferreri","year":"2005","journal-title":"J Clin Oncol"},{"key":"R69-2-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00003226-200401000-00012","article-title":"Combination of adult inclusion conjunctivitis and mucosa-associated lymphoid tissue (MALT) lymphoma in a young adult","volume":"231","author":"Yeung","year":"2004","journal-title":"Cornea"},{"key":"R70-2-20210203","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood.V104.11.2493.2493","article-title":"Periocular MALT (conjunctival\/orbital) lymphomas: complete responses with antibiotic therapy","volume":"104","author":"Coleman","year":"2004","journal-title":"Blood"},{"key":"R71-2-20210203","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/annonc\/mdj143","article-title":"\u201cBlind\u201d antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa","volume":"17","author":"Gr\u00fcnberger","year":"2006","journal-title":"Ann Oncol"},{"key":"R72-2-20210203","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.1984","article-title":"Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions","volume":"209","author":"Chanudet","year":"2006","journal-title":"J Pathol"},{"key":"R73-2-20210203","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2141.2005.05943.x","article-title":"Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients","volume":"132","author":"Daibata","year":"2006","journal-title":"Br J Haematol"},{"key":"R74-2-20210203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djj079","article-title":"Re: evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"98","author":"De Cremoux","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R75-2-20210203","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djj373","article-title":"Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial","volume":"98","author":"Ferreri","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R76-2-20210203","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.leukres.2006.01.015","article-title":"Chlamydia psittaci in ocular adnexal lymphoma: Japanese experience","volume":"30","author":"Liu","year":"2006","journal-title":"Leuk Res"},{"key":"R77-2-20210203","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.leukres.2005.12.003","article-title":"No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patients from the Netherlands","volume":"30","author":"Mulder","year":"2006","journal-title":"Leuk Res"},{"key":"R78-2-20210203","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.leukres.2005.09.012","article-title":"Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience","volume":"30","author":"Vargas","year":"2006","journal-title":"Leuk Res"},{"key":"R79-2-20210203","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/10428190600908174","article-title":"Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patients","volume":"48","author":"Gracia","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R80-2-20210203","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.leukres.2006.12.005","article-title":"Chlamydia psittaci, Helicobacter pylori and ocular adnexal lymphoma\u2013is there an association? The German experience","volume":"31","author":"Goebel","year":"2007","journal-title":"Leuk Res"},{"key":"R81-2-20210203","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/01.pas.0000249445.28713.88","article-title":"Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci","volume":"31","author":"Ruiz","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R82-2-20210203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1532\/IJH97.06065","article-title":"Absence of chlamydial infection in Japanese patients with ocular adnexal lymphoma of mucosa-associated lymphoid tissue","volume":"85","author":"Yakushijin","year":"2007","journal-title":"Int J Hematol"},{"key":"R83-2-20210203","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ajh.20962","article-title":"Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea","volume":"82","author":"Yoo","year":"2007","journal-title":"Am J Hematol"},{"key":"R84-2-20210203","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/10428190601132105","article-title":"Lack of an association between Chlamydia psittaci and ocular adnexal lymphoma","volume":"48","author":"Zhang","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R85-2-20210203","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon","year":"1991","journal-title":"Lancet"},{"key":"R86-2-20210203","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hon.762","article-title":"Nodal and splenic marginal zone B cell lymphomas","volume":"23","author":"Mollejo","year":"2005","journal-title":"Hematol Oncol"},{"key":"R87-2-20210203","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.blre.2004.03.002","article-title":"Splenic marginal zone lymphoma","volume":"19","author":"Oscier","year":"2005","journal-title":"Blood Rev"},{"key":"R88-2-20210203","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajh.20874","article-title":"Nongastric marginal zone B-cell lymphoma: analysis of 247 cases","volume":"82","author":"Oh","year":"2007","journal-title":"Am J Hematol"},{"key":"R89-2-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11864-006-0014-9","article-title":"Management of marginal zone lymphomas","volume":"7","author":"Thieblemont","year":"2006","journal-title":"Curr Treat Options Oncol"},{"key":"R90-2-20210203","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"key":"R91-2-20210203","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e3283043574","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:43:52Z","timestamp":1786038232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200808000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e3283043574","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}